For instance, loss-of-function mutations in DHHC9 and altered palmitoylation of its substrates have been identified in patients with neurodegenerative diseases, neurodevelopmental disorders, and patients with X-linked intellectual disability (XLID) [65,102,103,104]. Here, ZDHHC9 is linked to cask-related x-linked intellectual disability.